Oncology
Bridging the innovation gap: Scalable cell therapies, adapti...
Biotech must build manufacturing and trial models that make cell therapies scalable, accessible & commercially viable.
R&D
Decarbonising respiratory care requires a new kind of generi...
Generics manufacturers have long played a critical role in supporting the sustainability of the NHS, delivering affordable medicines at scale, expanding patient access, and helping healthca
Patients
Specialty medication access hinges on a 48-hour window
The vast majority of healthcare providers (HCPs) say that PA-related delays directly harm patient outcomes.
Patients
Decline in overdose deaths ≠ The end of the opioid crisis
Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to
Market Access
Navigating Europe's AI regulatory labyrinth: A strategic gui...
For US drug developers, bringing AI tools across the Atlantic introduces steep regulatory hurdles.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
